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Abstract
Objective—To compare 3 commonly used psychiatric symptom checklists (the Center for Epidemiological Studies Depression
Scale [CES-D], the Positive and Negative Affect Schedule, and the Endler Multidimensional Anxiety Scales [EMAS] to determine their sensitivity, specificity, and ability to discriminate between a disorder (Major Depression [MD], Generalized Anxiety Disorder [GAD], and no disorder. To compare the checklists for their ability to discriminate between type of disorder
(MD and GAD). To evaluate the discriminant ability of the subscales, particularly positive affect; whether the somatic items
in the CES-D artificially inflate affective scores; and the optimal cut off score for the CES-D.
Methods—We compared the 3 scales to diagnostic criterion of MD, GAD, and comorbid disorder using receiver operator characteristic (ROC) and logistic regression analyses. The sample consisted of a national panel of 415 individuals with rheumatoid
arthritis (RA).
Results—Each of the scales had high sensitivity and specificity (areas under the curve: CES-D = 0.92, negative affect = 0.88, positive affect and EMAS = 0.82). The CES-D, however, demonstrated better sensitivity and specificity than the positive affect and
the EMAS, but not the negative affect scale.
Conclusion—All 3 self-reports have high combined sensitivity and specificity as measures of affective disorders among RA
patients.
Keywords: affective disorder, distress, ROC

on the most frequently used measures of psychological distress (screening scales) may be inflated for a variety of reasons, calling into question the meaning currently ascribed
to the high distress levels seen in RA samples [1, 2, 8, 12].
The problems stem from 3 sources: 1) findings have not been
based on large, representative samples of RA patients; 2)
many depression and anxiety scales have adequate convergent validity but low discriminant validity; and 3) there may
be overlap between emotional distress items and typical RA
symptoms, i.e., criterion contamination [13]. There is particular concern that distress detected by the widely used Center
for Epidemiological Studies Depression Scale (CES-D) might
not be due to anxiety, depression, or concurrence of the two,
but rather that it is an artifact of overlap between CES-D somatic items and RA disease severity [1, 2, 11].

Introduction
Elevated levels of emotional distress indicated by depressive symptoms [1-4], diagnoses of depression [5-8],
and anxiety [3] are reported consistently across studies of
rheumatoid arthritis (RA) patients. Two reasons individuals with RA may be at greater risk for depression than the
general population are high levels of pain and/or functional impairment or a common neurobiologic mechanism
underlying both depression and RA [9-11]. An important
rival hypothesis is that elevated levels are a measurement
artifact.
An accurate assessment of the scope of emotional distress is important and researchers exploring a connection
between RA and affective disorders need reliable and valid
brief scales for screening individuals. Unfortunately, scores
368
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To address these limitations and to test the measurement artifact hypothesis, we employed a large, nationally
representative sample; used a structured diagnostic interview; used a multidimensional approach to enhance discriminant validity of screening scales suggested by Clark
and Watson [14]; and compared the combined sensitivity
and specificity of the CES-D with and without the somatic
items using receiver operator characteristic (ROC) curves.
This study also provides information to determine appropriate cut off scores for major depression (MD) and generalized anxiety disorder (GAD) for the continuous scales
commonly used on the RA population [15-18].
The intensity of depressive symptoms among individuals with RA has been widely studied using various indicators, including the CES-D [1, 2, 11], the Beck Depression
Inventory (BDI) [19, 20], and the Arthritis Impact Measurement Scales [3, 19, 21-23]. In samples of individuals with
RA, and using the conventional cut off for general populations, investigators have found rates of depression ranging from 23% using the BDI to 46% using the CES-D [1].
Although anxiety symptoms among RA patients have been
studied less frequently than symptoms of depression, studies that have assessed anxiety report rates comparable to
that reported for depression [3, 19].
When individuals with RA report high levels of psychological distress, it is not clear that researchers should
be reporting their findings as evidence of depression. Brief
self-report scales are economical and often have good convergent validity (indicated by high correlations with other
measures of the same construct), but they do not have good
discriminant validity (indicated by high correlations with
other measures of related but not identical constructs). It
is possible, of course, that while the underlying constructs
may be conceptually distinct, they may be empirically colinear. As a result, anxiety measures correlate or load
highly with depression measures and it is unclear whether
the distress that is being measured is due to anxiety, depression, or both [3, 12, 19, 24-26].
The somatic items included in most measures of depression and anxiety leave open the possibility of criterion contamination [13]. This contamination occurs when items that
were designed to assess dimensions of depression or anxiety
actually reflect aspects of RA. For example, questions about
fatigue or difficulty “getting going” can reflect depression,
the effects of RA, or both. Callahan et al [27] and Blalock et al
[1] found evidence consistent with the idea that the somatic
items of the CES-D are elevated among RA patients due to
RA symptoms, not greater depression. Rhee et al [11] found
some inflation of total CES-D scores in an RA sample attributable to somatic items. Blalock and colleagues [1] recommended that investigators remove 4 CES-D items to reduce
the inflation in scores deriving from RA disease severity.
These problems with common self-report screening
questionnaires have compromised our understanding of
connections between RA and affective disorders. Fortunately, methods are now available to improve the discriminant validity of questionnaire measures to differentiate between depression and anxiety. Two such methods are used

369

in this study. The first is a measure of state anxiety that
was designed specifically to distinguish anxiety from depression [25]. The second approach is based on the assessment of positive affect (PA) and negative affect (NA), as
suggested by Clark and Watson [14]. NA refers to feeling
“upset or unpleasantly engaged rather than peaceful,” and
PA refers to feeling a “zest for life and pleasurable engagement” [14]. These 2 affects can be measured as distinct and
orthogonal factors [14]. They discriminate between anxiety
and depression because NA is associated with both depression and anxiety, but low PA is unique to depression. These
findings have been reported in nonclinical [28, 29] and clinical samples [30-32]. In this study, we assess whether the
discriminant validity of the CES-D can be increased by using 2 subscales of the CES-D, identified in our previous
work [33], that closely resemble PA and NA.
In summary, we pose the following questions: 1)
Which of the commonly used distress scales demonstrates
the highest sensitivity and specificity? 2) Do subscale scores
improve our ability to distinguish between anxiety disorders and depressive disorders, and does the measurement
of PA enhance this distinction? 3) Do somatic items in depression scales, such as the CES-D, artificially inflate reports of the prevalence of affective disorder among individuals with RA, and does removing those items improve
scale sensitivity and specificity? 4) What is the optimal cut
off score on the widely used CES-D to detect affective disorder in a nationally representative RA sample?
Patients And Methods
Patients. A subset of patients from the National Rheumatoid Arthritis Study (NRAS) were recruited for this project. NRAS was a prospective panel study that completed its
tenth and final year in 1997-1998. The panel of 988 patients
with classic or definite RA [34] was recruited from a national, random sample of board-certified rheumatologists
(details of the recruitment are published elsewhere [[35]].
At the close of their eighth year interview, the 508 patients
remaining in the panel were asked if they would be interested in participating in an additional interview about their
emotional and physical well being. A total of 462 (91%)
agreed to the followup interview and 415 (90%) completed
it. Consistent with the 3:1 prevalence of RA among middleaged women to men, 83% of the sample was female. They
were largely upper middle-aged (mean 58 ± SD 9.7 years),
married (68%), and out of the labor force (65%). The relatively low employment rate is similar to other samples of
RA patients [36].
Methods. Diagnostic and scale responses were obtained by telephone interviews that lasted approximately
30 minutes. Current and lifetime psychiatric diagnoses of
MD, GAD, and comorbid disorder (CD) were obtained using the Semi-Structured Assessment for the Genetics of Alcoholism (SSAGA) [37-39] based on the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)
[40]. The SSAGA is suitable for either telephone or face-toface administration by lay interviewers [38, 39].
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The SSAGA was selected because it provides a complete and detailed lifetime psychiatric history for adults.
The SSAGA interview schedule covers the major Diagnostic
and Statistical Manual of Mental Disorders Revised Third Edition, DSM-IV, International Classification of Diseases, 10th Revision defined Axis I psychiatric disorders. In a combined
sample of subjects drawn from the general population and
from outpatient psychiatric patients, the SSAGA has been
shown to have good within and between site reliability
[37]. Using a combined sample of outpatient psychiatric
patients and subjects drawn from the community with unknown psychiatric histories, the SSAGA has been shown to
be valid compared with other standardized psychiatric diagnostic instruments, i.e., the Schedule for Clinical Assessment in Neuropsychiatry (SCAN) [38]. The SSAGA is currently being used in more than 55 studies in the US and 10
studies in foreign countries.
The SSAGA is useful in the arthritis population because
it links episodes of MD or GAD to comorbidities and flares.
Interviewers, supervised by a clinical psychologist, completed approximately 20 hours of SSAGA training. All of the
interviews were edited for accuracy by a research staff member with a master’s degree in psychology and several years
of experience with development of the interview.
Measures. The Center for Epidemiological Studies Depression Scale. The CES-D scale consists of 20 questions chosen
to reflect various aspects of depression, including depressed
mood, feelings of guilt and worthlessness, feelings of helplessness and hopelessness, psychomotor retardation, loss of
appetite, and sleep disturbance [41]. Respondents are asked
to think of the last week and report the frequency of occurrence for each item on the following 4-point scale 0) rarely,
that is less than 1 day; 1) some of the time, 1 to 2 days; 2) a
moderate amount of the time, 3 to 4 days; or 3) most or all
of the time, 5 to 7 days. Scores can range from 0-60. Aneshensel et al [42] found that phone and in person administrations produce comparable scores. Past studies show that the
CES-D demonstrates adequate test-retest stability, as well as
concurrent validity and construct validity [41].
Although the CES-D appears to suffer from the same
discriminant validity problems as other popular depression questionnaires used in arthritis research [1], it has
been chosen for this study for 3 reasons. First, along with
the BDI, it has been rated among the best self-report measures of depression and anxiety based on content validity
[43]. Second, it has been widely used for some time among
arthritis researchers, and knowledge about its validity or
how to improve it would be very useful in the analysis of
data appearing in the literature. Finally, previous analyses have identified the factor structure of the CES-D, which
may enhance its discriminant validity [33].
Blalock et al [1] identified 4 somatic CES-D items that
could be confounded with RA symptoms (I felt that everything I did was an effort, My sleep was restless, I felt hopeful about the future, I could not get going). We created a
version of the CES-D that removed these somatic items
and prorated the remaining items to retain the range of the
original scale.
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The state scale of the Endler Multidimensional Anxiety
Scales (EMAS). This scale was used to measure state anxiety [44]. The EMAS-State is a 20-item measure with each
item rated on a 5-point intensity scale. It includes a 10-item
cognitive-worry subscale and a 10-item autonomic-emotional scale. Previous studies report good reliability for
both scales (0.84 or better). Fifield [45] has reported that administration by telephone and questionnaire produce comparable results
The Positive and Negative Affect Schedule (PANAS). The
PANAS [32] was used as the measure of positive and negative affect. The measure includes two 10-item mood scales
for NA and PA, which form independent factors. Each
item is rated on a 5-point scale from 1 indicating felt very
slightly or not at all to 5 indicating felt very much. Watson et al [32] have reported extensively on the reliability
and validity of the scales, finding strong convergent and
discriminant validity with other lengthier mood measures
[32]. We used the time frame that refers to over the past
week to make the PANAS comparable to the CES-D and
the EMAS. Fifield [45] has reported that administration by
telephone and questionnaire produce comparable results
Diagnosis of affective disorder (MD, GAD, CD). DSM-IV
[40] criteria to qualify for a diagnosis of MD include 1) depressed mood or loss of interest and pleasure in things that
the individual usually cared about or enjoyed every day or
nearly every day for 2 weeks or more at some time in the
past while experiencing impaired role functioning; and 2)
4 of 8 additional symptoms: problems with appetite, sleep,
fatigue, energy, interest, self worth, cognition, or suicidal
ideas. The episode could not be due to injury, illness, medication or alcohol, childbirth, or the loss of a loved one
within certain time parameters. A diagnosis of current MD
required that symptoms occurred within 3 weeks of the interview, whereas a diagnosis of lifetime MD required that
the symptoms occurred anytime in the past but not in the
past 3 weeks.
DSM-IV criteria for GAD include 1) excessive anxiety
and worry for 6 months; 2) difficulty controlling worry; and
3) at least 3 of the following 6 symptoms experienced nearly
every day during the episode: restlessness, being easily fatigued, difficulty concentrating or mind going blank, irritability, muscle tension, sleep disturbance. Symptoms cannot be
due to the direct effects of a substance or medical condition,
they must manifest themselves in role impairment, and they
cannot be exclusively coincident with mood disorder. Current GAD required all of these criteria within the 6 months
preceding the interview, whereas lifetime GAD required the
same criteria for 6 months in the past prior to that time.
DSM-IV does not include criteria for a CD. Previous
studies show that those meeting criteria for both disorders
have more severe and persistent emotional symptoms with
more handicapped social lives [46, 47]. Therefore, we classified people who met full criteria for both MD and GAD
as CD for the preliminary analysis. For the ROC analysis,
people with CD are combined with the people diagnosed
with MD or GAD in a general affective disorder category
(n = 37) or, in the analyses attempting to discriminate be-
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tween MD and GAD, they are eliminated (n = 27) because
they can not be placed in either group.
Statistical analysis.We use a variety of methods to
assess the effectiveness of the 3 scales to discriminate between those with anxiety, depression, both, or neither. Preliminary analyses of convergent and discriminant validity
include bivariate correlations among the full and subscales
and analysis of variance (ANOVA) tests of the differences
in mean scale scores by affective disorder (MD, GAD, CD).
We used Scheffe and Bonferroni tests for multiple post hoc
comparisons between the groups. ROC curves simultaneously estimate the sensitivity and specificity of the screening scales, and provide significance tests for the differences
between scales. ROC analysis has been used in other studies to assess the sensitivity and specificity of screening tests
for depression and/or anxiety [15-17, 48]. However, ROC
analysis cannot evaluate the combined effect of subscales
to discriminate between groups. Interaction terms created
by multiplying subscale scores provide this information,
but cannot be used in ROC analysis. Therefore, we tested
the possibility that the interaction between the PA and depressed affect (DA) subscales of the CES-D and the PA and
NA subscales of the PANAS scale provide more information than the full scale or than the subscales in an additive
logistic regression model.
The specificity and the sensitivity rates for each scale
provide information about the ability of the instruments to
discriminate between those with a disorder and those without, and between disorders (MD and GAD). Determining
specificity and sensitivity usually requires choosing cut off
scores for the continuous scales, therefore making the results dependent on the selected cut off. Somoza and Mossman [49] and Metz [50] suggest ROC analysis as a way to
overcome the problem of having several cut off scores or
selecting only one. ROC analysis provides an overall description of a scale’s combined sensitivity and specificity
(ability to discriminate) throughout its entire range of possible cut off scores, summarized in an area score (Az).
ROC analysis creates an estimated, smoothed curve
with a confidence interval for generalizing to the population. Generalizing requires assuming that the scale’s scores
are normally distributed within each of the groups (disorder/no disorder or MD/GAD), even if the means in each
group are different (binormal assumption). Swets [51] indicates that the binormal assumption is valid for a wide variety of diagnostic tests, and Hanley [52] describes ROC analysis as robust to deviations from normality. We used the
CLABROC program, part of the ROCKIT software [53], to
conduct the ROC analysis. CLABROC is a maximum likelihood program that creates estimated curves for correlated,
paired, continuous distributions. The output from the
CLABROC program provides information to create ROC
curves, a confidence interval around the area under the
curve (Az), and comparisons between 2 scales on the same
group of people. The Az parameter indicates how much
the scale improves discrimination over chance. The Az is
an overall index of the accuracy of the scale. Higher Az
scores indicate greater combined sensitivity and specificity.
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Differences in the accuracy of the scales were tested using
the area under the curve test (95% confidence level, 2-tailed
test). According to Mossman and Somoza [54], the Az represents the probability that 1 of the patients who was diagnosed with the scale as having an affective disorder ranked
higher on a particular scale than another patient, who was
randomly identified and did not have an affective disorder,
ranked on the same particular scale.
To use the ROC analysis to select an optimum cut-off
score for a scale, prevalence rates need to be specified because discrimination by score varies by prevalence. Because the optimal cut-off scores depend on the prevalence
in the population and the research/clinical situation, it is
impossible to provide a single best score. However, we calculated the true positive rate and the false positive rate for
various cut off scores for all of the scales (available from
the first author) [16].
Logistic regression analysis provides a way to assess
the effectiveness of combinations of the subscales (interaction terms) to discriminate between those with and those
without an affective disorder, or between disorders. Interaction terms that combine information from the PA and
NA subscales of the PANAS and the PA and DA subscales
of CES-D should have larger coefficients than either scale
alone if Clark and Watson’s [14] tripartitie model of affective disorder is correct. However, a problem arises when
trying to interpret odds ratios when the independent variables are continuous. Because the coefficients describe
changes per unit change in the independent variable, for
the coefficients to be comparable, the independent variables
need to be standardized by subtracting the scale mean from
each value of the independent variable and dividing by the
standard deviation of the independent variable.
Results
Sample description and prevalence of affective disorders. Similar to the RA population, most of the study participants are women (83%) and married (68%), but only
one-third are currently employed (35%). At entry into the
study, participants had been living with a diagnosis of RA
for an average of 10 years; the mean age at diagnosis was
39.5 years. Median family income was $35,000 and median
education was 1 year of post-high school education. Average pain and fatigue levels in the sample during the eighth
wave of the study were at the middle of the range (45 for
pain, 51 for fatigue). Of the 415 participants in this study,
9% met the criteria for current major depressive episode
(MD = 4%), current generalized anxiety disorder (GAD =
3%), or both simultaneously (CD = 2%).
Means and alpha reliabilities of the scales. All of
the screening scales had adequate alpha reliabilities (Table 1). The lowest was 0.71 for the interpersonal subscale
of the CES-D, the highest is 0.93 for the EMAS summary
scale. We also constructed a CES-D scale with the somatic
items removed (CES-Dnoso). The items for this scale were
prorated to make a scale with the same possible range of
scores as the original CES-D scale. The mean for the scale
without the somatic items (mean = 10.17) is lower than for
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the scale with the somatic items (mean = 12.23, paired t-test
P < 0.05); however, the 2 scales were almost perfectly correlated (0.99). Squaring this coefficient (R2 = 0.97) indicates
that less than 3% of the original CES-D score is explained
by the somatic items. Although the scores were significantly lower when the somatic items were removed, suggesting some RA contamination, the magnitude of the difference is small. We further explore how much the somatic
items inflate the CES-D scores among people with RA using the ROC analyses.
Correlations among the scales and subscales. Table
2 provides the correlations among the scales and subscales
for all of the cases (n = 415, bottom half of the diagonal)
and for just those cases with an affective disorder (n = 37,
top half of the diagonal).
We focus first on the correlations in the entire sample.
The first 5 columns contain the subscales of the CES-D, as
identified by Sheehan et al [33]. All of the correlations are
above 0.60, indicating adequate convergent validity. All
of the subscales had strong positive correlations with the
full scale (0.80-0.93). These patterns of correlations provide evidence of good convergent validity for the CES-D
subscales.
Next, we assessed the correlations between the subscales of the CES-D and the subscales of the EMAS and
the PANAS. Some of the correlations between the depression subscales and the anxiety subscales are quite high (5
correlations are higher than 0.70, the lowest was 0.43). The
strong positive correlation between both the depression
subscales (CES-D) and the anxiety subscales (EMAS) and
NA indicates that both scales were tapping negative affect.
NA and PA had, as they should, a modest correlation (r =
0.36).The correlations for study participants with a diagnosis of either MD or GAD (n = 27) are similar to the full sample. The smallest correlation is -0.05, the largest is 0.86. The
overall pattern of correlations among those with an affective disorder is similar to the pattern among all study participants; there is better convergent validity than discriminant validity.
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Table 1. Means and reliabilities for the CES-D, EMAS, and PANAS with subscales (n = 415)*
Scale

Mean

Alpha
reliability

SD

Min-max

CES-D
12.23
11.00
0.75
0-50
   CES-Dnoso
10.17
10.73
0.72
0-47
CES-D subscales	 	 	 	 
   Somatic
5.79
4.44
0.83
0-21
   Interpersonal
0.96
1.68
0.71
0-10
   Depressive
2.66
3.37
0.88
0-15
   Positive
9.19
3.02
0.83
0-12
EMAS
29.83
12.05
0.93
20-84
   Autonomic worry
14.50
5.76
0.83
10-40
   Cognitive worry
15.21
6.95
0.91
10-40
PANAS positive affect    
scale
30.49
7.98
0.89
10-50
PANAS negative affect
   scale
17.69
7.48
0.91
10-50
  * CES-D = Center for Epidemiological Studies Depression Scale;
EMAS = Endler Multidimensional Anxiety Scales; PANAS = Positive
and Negative Affect Schedule; SD = standard deviation; Min = minimum; max = maximum; CES-Dnoso = CES-D with somatic items
removed.

Distinguishing between MD, GAD, and CD. We
compared mean CES-D, NA, PA, and EMAS scores for
those with no affective disorder (n = 378), those with MD
(n = 16), GAD (n = 11), and CD (n = 10) using ANOVA (Table 3).
The group without an affective disorder had lower average scores on all of the scales than the groups with a disorder. The average scores for those in the affective disorder categories were at least 1 standard deviation above the
mean for all scales. These results indicate that each of the
screening questionnaires were able to distinguish between
individuals with an affective disorder and those without
one. There were large overlaps in the confidence intervals
between types of disorders (GAD, MD, or CD), suggesting
that none of the scales were able to differentiate between
the types of disorders. Furthermore, the subscales showed
no apparent advantage over the full CES-D or EMAS. PA
scores were comparable for those with GAD, MD, or both.

Table 2. Correlations among the scales and subscales*
1

2

3

4

5

6

7

8

9

1 CES-D interpersonal		
0.46
0.56
0.51
0.76
0.48
0.35
0.45
0.25
2 CES-D somatic vegitative
0.63		
0.70
0.32
0.85
0.53
0.34
0.47
0.22
3 CES-D depressed affect
0.73
0.79		
0.34
0.86
0.47
0.27
0.40
0.33
4 CES-D positive affect (reversed)
0.60
0.61
0.68		
0.64
0.38
0.08
0.25
0.41
5 CES-D summary score
0.80
0.91
0.93
0.82		
0.59
0.34
0.50
0.37
6 EMAS cognitive worry
0.65
0.73
0.70
0.59
0.77		
0.72
0.93
0.09
7 EMAS autonomic worry
0.52
0.65
0.57
0.43
0.63
0.75		
0.92
-0.20
8 EMAS summary score
0.63
0.74
0.69
0.56
0.76
0.95
0.92		
-0.05
9 Positive affect (reversed)
0.41
0.49
0.47
0.63
0.58
0.41
0.30
0.38		
10 Negative affect
0.67
0.72
0.75
0.60
0.79
0.76
0.64
0.75
0.36

10
0.46
0.41
0.51
0.45
0.57
0.53
0.30
0.45
0.10

  * Bottom half contains all study participants (n = 415), top half (italics) contains just those with an affective disorder (n = 37). All of the correlations in the bottom left half are significant at the 0.01 level (2-tailed) (n = 415). All of the correlations in the top right half are significant at the 0.05
level (2-tailed) except for those in bold (P values are greater than 0.05) (n = 37). See Table 1 for definitions.
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Table 3. Means, SDs, and 95% CIs for the scales by affective disorder category*
Scale

Affective disorder category

N

Positive affect

No disorder
MD
GAD
CD
No disorder
MD
GAD
CD
No disorder
MD
GAD
CD
No disorder
MD
GAD
CD
No disorder
MD
GAD
CD

378
16
11
10
378
16
11
10
378
16
11
10
378
16
11
10
378
16
10
10

Negative affect

EMAS

CES-D

CES-Dnoso

Mean
31.30
22.81
22.18
21.40
16.66
27.25
28.73
29.10
28.40
47.94
41.09
42.30
10.48
30.94
27.27
32.20
8.46
27.97
24.50
29.63

SD
7.62
7.53
6.66
6.69
6.62
7.61
9.26
6.74
10.64
16.84
16.08
13.74
9.38
10.00
10.07
11.37
9.09
10.06
10.66
12.15

95% CI
30.53-32.07
18.80-26.82
17.71-26.66
16.62-26.18
15.99-17.33
23.19-31.31
22.50-34.95
24.28-33.92
27.33-29.48
38.96-56.91
30.29-51.89
32.47-52.13
9.53-11.42
25.61-36.26
20.51-34.04
24.07-40.33
7.54-9.38
22.61-33.33
16.88-32.12
20.93-38.32

  * SDs = standard deviations; 95% CIs = 95% confidence intervals; MD = major depression; GAD = generalized anxiety disorder; CD = comorbid
disorder. See Table 1 for other definitions.

Figure 1. Receiver operator characteristic curves for the full
scales (Center for Epidemiological Studies Depression Scale
[CES-D], negative affect [NA], Endler Multidimensional Anxiety Scales [EMAS], and positive affect [PA].

ROC analysis. We first used ROC analysis to test the
ability of the scales and subscales to discriminate between
those with GAD and those with MD (n = 27). Because the
CD participants fit in neither group, they are omitted from
this analysis and only are incorporated in the analysis of
those with and those without a disorder. All of the scales
showed poor discriminant validity (Az scores range from
0.45 to 0.66; none were significantly better than chance).
Only 2 of the subscales had Az scores that were different
from their full scales: the interpersonal and DA subscales of
the CES-D were each significantly worse than the full CESD at discriminating between depression and anxiety.
Figure 1 shows the ROC analyses of the full scales using affective disorder (AD), that is MD or GAD or both, as
the criterion. The ROC curves for the CES-D, NA, EMAS,
and PA show areas under the curve ranging from a high of

0.92 for the CES-D to 0.82 for the PA. The CES-D had a significantly higher area under the curve than the EMAS (Az
= 0.92 versus 0.82; P = 0.003) and the PA (Az = 0.92 versus
0.82; P = 0.003), but not the NA. These results indicate that
the CES-D is better than the EMAS, PA, or NA at differentiating between those with and those without an affective disorder. Although not shown in the figure, the curve
for the CES-D without the somatic items was not different
from the CES-D with the somatic items.
All of the Azs were high, suggesting that all of the
scales had good combined sensitivity and specificity (all
are higher than 0.80) to predict membership in the affective disorder group compared with the nonaffective disorder group. We also tested the subscales of the CES-D and
the EMAS compared with the full scales to ascertain if they
added information hidden in the combined scales (Figure
2). None of the subscales had significantly higher Az scores
than the full scales. The interpersonal, DA, and PA subscales had significantly lower Az scores than the full CESD scale.
Logistic regression analysis. We tested the possibility that the interaction between the PA and DA subscales
of the CES-D and the PA and NA subscales of the PANAS
scale provide more information than either full scale or
than the subscales in an additive logistic regression model.
The EMAS subscales have not previously been examined
for interactive effects; however, we decided to test the possibility that the subscales might be more effective than the
full scale in a fashion parallel to the CES-D and PANAS.
We focused only on the whole sample (n = 415) because
the disordered subsample did not have sufficient cases for
the analysis (the Hoesmer-Lemeshow test showed that several categories had fewer than the minimum required 5 expected cases).
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The ROC program automatically selects cut point
scores from the raw data. Because cut points of 16 and 19
have been suggested in past research, we examined these 2
cut point scores for the full CES-D and the CES-Dnoso (somatic items removed) using simple cross-tabulated data
(Table 4). In this sample, there was a difference of only 1
true case missed when 19 was used as a cut score, compared with 16, but there were 22 more false positives with
16. Like other studies using the CES-D, we found that the
specificity (0.89) of the CES-D is much better than the sensitivity (0.24) at the standard cut off score of 16.

Figure 2. Receiver operator characteristic curves for the full
and subscales of the Center for Epidemiological Studies Depression Scale (CESD) and Endler Multidimensional Anxiety Scales (EMAS) (n = 415). CESD-DA = CESD depressed affect; CESD-SV = CESD somatic vegitative; CESD-PA = CESD
positive affect; CESD-IN = CESD interpersonal; EMAS-AW
= EMAS autonomic worry; EMAS-CW = EMAS cognitive
worry.

The logistic regression analysis revealed that both
the full CES-D and the PA and DA subscales of the CESD showed significant positive associations with the likelihood of having an affective disorder diagnosis. Combining information from the DA and PA subscales does not
contribute to the simple additive model. The pattern is the
same for the PANAS, but slightly different for the EMAS.
For the EMAS, when both of the subscales (autonomic
worry and cognitive worry) were in the model, the autonomic worry subscale ceased to be a significant predictor,
suggesting that there was considerable overlap between
these subscales.
Cut point for the CES-D. ROC analysis also allowed us
to evaluate the best cut point for determining membership
in the affective disorder category. The generally accepted
cut point for the CES-D is 16. Some researchers have questioned the applicability of this value for the RA population
because of the possible criterion contamination of the somatic items. We saw little evidence of contamination. Both
the false positives and the true positives increased substantially when the cut point scores were increased from 17.5 to
20.5. There was very little difference between scores of 16.5
and 17.5.

Discussion
This study provided a unique opportunity to review
the usefulness of 3 popular scales of depression and anxiety
for use as screeners in RA research. Its uniqueness stems
from the national representative sample and the availability of both screener and diagnostic interview scores. Using
these data, we found that it is possible to detect affective
disorders among people with RA using short symptom
scales. Furthermore, we found much lower rates of depression and anxiety in this sample than reported in other RA
studies; the percentages are closer to the national average
than previously found in RA samples [55]. We do not attribute this lower rate to our decision to exclude dysthymia
from our analyses, because only an additional 2% of the
sample (8 cases) met criteria for dysthymia only. Rather,
we conclude that higher rates of depression and depressive symptoms found in other studies are more likely due
to the characteristics of the samples than weaknesses in the
scales, because the scales, particularly the CES-D, demonstrated high combined sensitivity and specificity.
Similar to Breslau [12], we found that the CES-D does
not differentiate between MD and GAD, but does detect
high levels of depression and anxiety equally well. None of
the self-report measures of distress discriminated between
DSM-IV MD and GAD. Despite the promise of Clark and
Watson’s [14] tripartite model for differentiating between
anxiety and depression using positive and negative affect
subscales, PA did not differentiate between MD and GAD
in this sample. We do not have a satisfactory explanation
for this result. Possible explanations include sample-specific findings, a small number of individuals with MD or
GAD, something particular about the RA population, or
that MD and GAD share too much of a common core to be
discernible with general scales. The evidence of comorbidity in this and other studies suggests that differentiating between MD and GAD may be less important than identifying the existence of an affective disorder.

Table 4. Comparing the CES-D and the CES-Dnoso at 2 conventional cut points (n = 415)*
Scale
CES-D
CES-Dnoso
CES-D
CES-Dnoso

Cut point

n (%)

16
16
19
19

122 (29)
114 (27)
99 (24)
86 (21)

True positives
missed
4
4
5
8

False
positives
89
81
67
57

Sensitivity
0.89
0.89
0.86
0.78

  * CES-D = Center for Epidemiological Studies Depression Scale; CES-Dnoso = CES-D with somatic items removed.

Specificity
0.24
0.21
0.18
0.15

self-reports of distress and affective disorder diagnoses in rheumatoid arthritis

Because the consequences of comorbidity are quite
high, physicians should attempt to detect and treat those
cases that emerge. In addition to RA-affective disorder comorbidity, there is evidence of comorbidity among anxiety disorders. Fifty to sixty percent of individuals who
meet criteria for 1 anxiety disorder diagnosis also meet criteria for additional comorbid anxiety diagnoses [56]. Individuals with anxiety disorders are also likely to have major depression and substance use disorders [57]. When they
occur together, anxiety disorders tend to precede the development of mood disorders, such as depression or substance use [58]. This temporal ordering suggests that anxiety may contribute to the development of other psychiatric
problems, making early detection a high priority.
What do these results suggest for clinical practice and
future research on RA/affective disorder connections? In
clinical practices where the costs of false positives are low,
using a cut point of 16 for the CES-D with followup screening seems prudent. In prevalence research where questions
about the relationship between RA and affective disorders
are the focus, a cut point of 19 for the CES-D is more conservative and therefore preferable. If interview time is limited, using the DA subscale of the CES-D is almost as reliable as the full scale; however, cut points for the subscale
need to be established.
Researchers should be cautious in assuming a higher
prevalence of MD or GAD in RA populations. This study,
using a representative sample and diagnostic interview
schedule derived diagnoses, shows similar rates to a general population national survey. Despite similar numbers,
because the consequences of comorbidity are greater than
each disorder alone, it is essential to identify those meeting criteria for both affective disorders, and to continue to
explore connections between chronic illnesses such as RA
and affective disorders.
References
1

2
3
4
5
6
7
8

Blalock SJ, DeVellis RF, Brown GK, Wallston KA. Validity of the Center for Epidemiological Studies Depression
Scale in arthritis populations. Arthritis Rheum 1989; 32:
991-7.
Fifield J, Reisine S. Characterizing the meaning of psychological distress in rheumatoid arthritis. Arthritis Care Res
1992; 5: 184-91.
Hawley DJ, Wolfe F. Anxiety and depression in patients
with rheumatoid arthritis: a prospective study of 400 patients. J Rheumatol 1988; 15: 932-41.
Katz PP, Yelin EH. Prevalence and correlates of depressive symptoms among persons with rheumatoid arthritis.
J Rheumatol 1993; 20: 790-6.
Zathiropoulos G, Barry H. Depression in rheumatoid disease. Ann Rheum Dis 1974; 33: 132-5.
Rimon R. Depression in rheumatoid arthritis. Ann Clin Res
1974; 6: 171-5.
Rimon R, Laakso R. Overt psychopathology in rheumatoid arthritis: a fifteen year follow-up study. Scand J Rheumatol 1984; 13: 324-8.
Frank RG, Beck NC, Parker JC, Kashani JH, Elliott TR,

9
10
11

12

13
14
15
16

17

18
19

20
21

22
23

24
25

375

Haut AE, et al. Depression in rheumatoid arthritis. J Rheumatol 1988; 15: 920-31.
Sternberg E, Chrousos GP, Wilder RL, Gold PW. The
stress response and the regulation of inflammatory disease. Ann Intern Med 1992; 117: 854-66.
Rechlin T, Weis M, Kaschka W. Is diurnal variation of
mood associated with parasympathetic activity? J Affect
Disord 1995; 34: 249-55.
Rhee SH, Petroski GF, Parker JC, Smarr KL, Wright GE,
Multon KD, et al. A confirmatory factor analysis of the
Center for Epidemiologic Studies Depression Scale in
rheumatoid arthritis patients: additional evidence for a
four-factor model. Arthritis Care Res 1999; 12: 392-400.
Breslau N. Depressive symptoms, major depression, and
generalized anxiety: a comparison of self-reports on CESD and results from diagnostic interviews. Psychiatry Res
1985; 15: 219-29.
Pincus T, Callahan LF. Depression scales in rheumatoid
arthritis: criterion contamination in interpretation of patient responses. Patient Educ Couns 1993; 20: 133-43.
Clark L, Watson D. Tripartate model of anxiety and depression: psychometric evidence and taxonomic implications. J Abnorm Child Psychol 1991; 100: 316-36.
Somoza E, Mossman D. “Biological markers” and psychiatric diagnosis: risk-benefit balancing using ROC analysis.
Biol Psychiatry 1991; 29: 811-26.
Somoza E, Steer RA, Beck AT, Clark DA. Differentiating
major depression and panic disorders by self-report and
clinical rating scales: ROC analysis and information theory. Behav Res Ther 1994; 32: 771-82.
Weinstein MC, Berwich DM, Goldman PA, Murphy JM,
Barsky AJ. A comparison of three psychiatric screening
tests using receiver operating characteristic (ROC) analysis. Med Care 1989; 27: 593-607.
Wyshak G, Barsky AJ. Relationship between patient selfratings and physician ratings of general health, depression, and anxiety. Arch Fam Med 1994; 3: 419-24.
Hagglund KJ, Roth DL, Haley WE, Alarcon GS. Discriminant and convergent validity of self-report measures of
affective distress in patients with rheumatoid arthritis. J
Rheumatol 1989; 16: 1428-32.
Smith TW, Peck JR, Ward JR. Helplessness and depression in rheumatoid arthritis. Health Psychol 1990; 9: 377-89.
Parker J, Smarr K, Anderson S, Hewett J, Walker S,
Bridges A, et al. Relationship of changes in helplessness
and depression to disease activity in rheumatoid arthritis.
J Rheumatol 1992; 19: 1901-5.
Parker JC, Wright GE. The implications of depression for
pain and disability in rheumatoid arthritis. Arthritis Care
Res 1995; 8: 279-83.
Pincus T, et al. Elevated MMPI scores for hypochondriasis, depression, and hysteria in patients with rheumatoid
arthritis reflect disease rather than psychological status.
Arthritis Rheum 1986; 29: 1456-66.
Gotlib I. Depression and general psychopathology in university students. J Abnorm Psychol 1984; 93: 19-30.
Endler N, Cox BJ, Parker JD, Bagby RM. Self-reports of
depression and state-trait anxiety: evidence for differential assessment. J Pers Soc Psychol 1992; 63: 832-8.

mcquillan et al. in arthritis care

376
26

27

28

29
30
31

32
33
34
35

36
37

38
39

40
41
42

Tanaka-Matsumi J, Kameoka VA. Reliabilities and concurrent validities of popular self-report measures of depression, anxiety, and social desirability. J Consult Clin Psychol
1986; 54: 328-33.
Callahan LF, Kaplan MR, Pincus T. The Beck Depression
Inventory, Center for Epidemiological Studies Depression
Scale (CES-D), and General Well-Being Schedule depression subscale in rheumatoid arthritis: criterion contamination of responses. Arthritis Care Res 1991; 4: 3-11.
Tellegen A. Structures of mood and personality and their
relevance to assessing anxiety with an emphasis on selfreport. In: Tuma A , Maser JD , editors. Anxiety and the
anxiety disorders. Hillsdale (NJ): Erlbaum; 1985. p. 681-706.
Watson D, Tellegen A. Toward a consensual structure of
mood. Psychol Bull 1985; 98: 219-35.
Bouman TK, Luteijn F. Relations between the pleasant
events schedule, depression, and other aspects of psychopathology. J Abnorm Psychol 1986; 95: 373-7.
Hall C. Differential relationships of pleasure and distress
with depression and anxiety over a past, present and future time framework [dissertation]. Minneapolis: University of Minnesota; 1977.
Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect:
the PANAS scales. J Personal Soc Psychol 1988; 54: 1063-70.
Sheehan TJ, Fifield J, Reisine S, Tennen H. The measurement structure of the Center for Epidemiologic Studies
Depression Scale. J Pers Assess 1995; 64: 507-21.
Ropes M, Bennett G, Cobb S, Jacox R, Jessar R. 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull
Rheum Dis 1958; 9: 175-6.
Reisine S, Fifield J, Winkelman DK. Characteristics of
rheumatoid arthritis patients: who participates in longterm research and who drops out? Arthritis Care Res 2000;
13: 3-10.
Yelin E, Henke C, Epstein W. The work dynamics of the
person with rheumatoid arthritis. Arthritis Rheum 1987;
30: 507-12.
Bucholz KK, Cadoret R, Cloninger CR, Dinwiddie SH,
Hesselbrock VM, Nurnberger JI Jr, et al. A new, semistructured psychiatric interview for use in genetic linkage
studies: a report on the reliability of the SSAGA. J Stud Alcohol 1994; 55: 149-58.
Hesselbrock MN, Easton C, Bucholz KK, Schuckit M, Hesselbrock V. A validity study of the SSAGA - a comparison
with the SCAN. Addiction 1999; 94: 1361-70.
Hesselbrock MN, Hesselbrock VM, Tennen H, Meyer RE,
Workman KL. Methodological considerations in the assessment of depression in alcoholics. J Consult Clin Psychol
1983; 51: 399-405.
Diagnostic and Statistical Manual of Mental Disorders. Washington (DC): American Psychiatric Association; 1994.
Radloff L. The CES-D scale: a self report depression scale
for research in the general population. Appl Psychol Measure 1977; 1: 385-401.
Aneshensel CS, Frerichs RR, Clark VA, Yokopenic PA.
Measuring depression in the community: a comparison of
telephone and personal interviews. Public Opin Q 1982; 46:
110-21.

43

44
45

46
47

48
49
50
51
52
53
54
55

56
57

58

&

research

49 (2003)

Gotlib I, Cane D. Self-report assessment of depression and
anxiety. In: Kendall PC , Watson D , editors. Anxiety and
depression: distinctive and overlapping features. New York:
Academic Press; 1989. p. 131-69.
Endler N, Edwards J, Vitelli R. Endler Multidimensional
Anxiety Scales (EMAS): manual. Los Angeles: Western Psychological Services; 1991.
Fifield J, Tennen H, Reisine S, Hesselbrock V, Sheehan TJ,
McQuillan J, et al. A comparison of risk factors for major depression and depressive symptoms reports in rheumatoid arthritis. Arthritis Research Conference. Bethesda
(MD), NIAMS, May 29-June 1 1997.
Hecht H, von Zerssen D. Anxiety and depression in a
community sample: the influence of comorbidity on social
functioning. J Affect Disord 1990; 18: 137-44.
Newman SC, Bland RC. Life events and the 1-year prevalence of major depressive episode, generalized anxiety disorder, and panic disorder in a community sample.
Compr Psychiatry 1994; 35: 76-82.
Wyshak G, Barsky AJ, Klerman GL. Comparison of psychiatric screening tests in a general medical setting using
ROC analysis. Med Care 1991; 29: 775-85.
Somoza E, Mossman D. ROC curves and the binormal assumption. J Neuropsychiatry Clin Neurosci 1991; 3: 436-9.
Metz CE. Basic principles of ROC analysis. Semin Nucl
Med 1978; 8: 283-98.
Swets JA. ROC analysis applied to the evaluation of medical imaging techniques. Invest Radiol 1979; 14: 109-21.
Hanley JA. The robustness of the binormal assumptions used in fitting ROC curves. Med Decis Making 1988;
8: 197-203.
Metz CE, Herman BA, Roe CA. Statistical comparison of
two ROC-curve estimates obtained from partially-paired
datasets. Med Decis Making 1998; 18: 110-21.
Mossman D, Somoza E. ROC curves, test accuracy, and
the description of diagnostic tests. J Neuropsych Clin Neurosci 1991; 3: 330-3.
Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes
M, Eshleman S, et al. Lifetime and 12-month prevalence
of DSM-III-R psychiatric disorders in the United States:
results from the National Comorbidity Survey. Arch Gen
Psychiatry 1994; 51: 8-19.
Brown TA, Barlow DH. Comobidity among anxiety disorders: implications for treatment and DSM-IV. J Consult
Clin Psychol 1992; 60: 835-44.
Angst J, Vollrath M, Merikangas KR, Ernst C. Comorbidity of anxiety and depression in the Zurich Cohort Study
of Young Adults. In: Maser JD , Cloninger CR , editors.
Comorbidity of mood and anxiety disorders. Washington
(DC): American Psychiatric Press; 1990.
Hesselbrock MN, Meyer RE, Keener JJ. Psychopathology
in hospitalized alcoholics. Arch Gen Psych 1985; 42: 1050-5.

